Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 89
Filtrar
1.
Cancer Res ; 51(16): 4450-4, 1991 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-1868466

RESUMEN

An increase in expression of the GLUT1 glucose transporter gene has been observed to be associated with an increase in glucose transport activity upon oncogenic transformation of the cells. Increased expression of this glucose transporter isoform has been also observed in fetal tissues. To investigate the consequences of this phenomenon on cellular metabolism and cell growth, an expression vector containing the GLUT1 glucose transporter complementary DNA was transfected into Chinese hamster ovary cells. Overexpression of this glucose transporter isoform resulted in an increase in not only glucose uptake and utilization but also thymidine uptake when cells were exposed to glucose-deficient conditions. This increase in glucose metabolism and DNA synthesis may play an important role on the growth and/or survival of cancer cells and fetal tissues.


Asunto(s)
Replicación del ADN , Glucosa/farmacología , Proteínas de Transporte de Monosacáridos/fisiología , Timidina/metabolismo , 3-O-Metilglucosa , Secuencia de Aminoácidos , Animales , Línea Celular , Cricetinae , Cricetulus , Replicación del ADN/efectos de los fármacos , Desoxiglucosa/metabolismo , Femenino , Técnica del Anticuerpo Fluorescente , Glucosa/metabolismo , Sueros Inmunes , Cinética , Metilglucósidos/metabolismo , Datos de Secuencia Molecular , Proteínas de Transporte de Monosacáridos/análisis , Proteínas de Transporte de Monosacáridos/genética , Oligopéptidos/síntesis química , Ovario , Transfección
2.
Cancer Res ; 44(3): 1288-300, 1984 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-6318984

RESUMEN

We have studied nine Hodgkin's lymphoma (HD) and ten non-Hodgkin's lymphoma (NHL) patients with extraordinarily high anti-viral capsid antigen (VCA) titers (greater than 5120). Controls were 13 HD and 23 NHL patients with anti-VCA titers between 40 and 2560. High anti-VCA titers were present in NHL patients at the time of diagnosis or within 16 months, whereas the rise of anti-VCA titers in HD patients appeared to be a late event during the clinical course of the disease (mean time from diagnosis, 68 months). In particular, we have asked whether the exceptionally high anti-Epstein-Barr virus (EBV) titers in some HD and NHL patients can be correlated to some of the EBV-specific and -nonspecific parameters of cell-mediated immunity. The battery of non-EBV-specific immunological tests included the assessment of natural killer cell activity and the analysis of T-lymphocyte subclasses according to surface markers, together with spontaneous and mitogen-induced DNA synthesis and their helper or suppressor activity on PWM-generated immunoglobulin synthesis. Outgrowth inhibition (Ol) and leukocyte migration inhibition were used to assess EBV-specific cell-mediated immunity. The majority of the high-titer HD and NHL patients showed a drastically reduced OKT4:OKT8 ratio in their peripheral lymphocyte population. Low-titer HD and NHL patients showed no such reduction. There was no strict correlation between the number of OKT8-positive cells and suppressor activity in the functional PWM-induced immunoglobulin production test. Part of the high-titer HD patients showed defective cellular responses in the outgrowth inhibition test, directed against the proliferation of EBV-transformed (EBV-determined nuclear antigen-positive) cells. Some of them showed also a deficient leukocyte migration inhibition response to EBV-determined nuclear antigen but, interestingly, not to early antigen-VCA. In the NHL group, only one of the high-titer patients showed a similar defect. None of the low-titer HD and NHL patients showed such defects.


Asunto(s)
Citotoxicidad Celular Dependiente de Anticuerpos , Antígenos Virales/análisis , Herpesvirus Humano 4/inmunología , Enfermedad de Hodgkin/microbiología , Linfoma/microbiología , Adulto , Anciano , Anticuerpos , Complejo Antígeno-Anticuerpo , Antígenos Nucleares del Virus de Epstein-Barr , Femenino , Enfermedad de Hodgkin/inmunología , Humanos , Linfoma/clasificación , Linfoma/inmunología , Masculino , Persona de Mediana Edad
3.
J Clin Oncol ; 15(8): 2954-65, 1997 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9256140

RESUMEN

PURPOSE: To determine whether macrophage colony-stimulating factor (M-CSF) reduces the incidence and duration of febrile neutropenia during three courses of intensive consolidation therapy and whether it shortens time to complete consolidation therapy. PATIENTS AND METHODS: In 198 adult patients with acute myeloid leukemia (AML) in complete remission (CR), M-CSF (8 x 10(6) U/d) or placebo was administered from 1 day after the end of each consolidation chemotherapy for 14 days. RESULTS: The duration and incidence of febrile neutropenia was significantly reduced by 34% (P = .00285) and 17% (P = .02065), respectively, in 88 assessable patients in the M-CSF group compared with those in 94 assessable patients in the placebo group. Patients in the M-CSF group had 565 days and 133 episodes of febrile neutropenia during 7,901 days at risk, while patients in the placebo group had 977 days and 185 episodes during 9,077 days at risk. The median period required to finish the three courses of consolidation therapy was 93 days in the M-CSF group, which was significantly shorter than 110 days in placebo group (P = .0050). In the M-CSF group, the recovery of neutrophils and platelets was significantly faster (P = .0348 and P = 0.0364, respectively), the administration of systemic antimicrobial agents tended to be less (P = .0839), and the frequency of platelet transfusion (P = .0259) and the total volume of transfused platelets (P = .0292) were significantly less. However, there was no significant difference in the disease-free survival. CONCLUSION: M-CSF significantly reduced the incidence and duration of febrile neutropenia during the intensive consolidation therapy, and shortened the time to complete consolidation chemotherapy in AML.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Fiebre/terapia , Leucemia Mieloide/tratamiento farmacológico , Factor Estimulante de Colonias de Macrófagos/uso terapéutico , Neutropenia/terapia , Enfermedad Aguda , Adolescente , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Método Doble Ciego , Femenino , Fiebre/inducido químicamente , Factor Estimulante de Colonias de Granulocitos/uso terapéutico , Humanos , Leucemia Mieloide/sangre , Recuento de Leucocitos , Factor Estimulante de Colonias de Macrófagos/efectos adversos , Factor Estimulante de Colonias de Macrófagos/orina , Masculino , Persona de Mediana Edad , Neutropenia/sangre , Neutropenia/inducido químicamente , Neutrófilos , Recuento de Plaquetas , Factores de Tiempo
4.
Diabetes ; 40(3): 315-8, 1991 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-1999271

RESUMEN

A radioimmunoassay for the GLUT1 glucose transporter was developed with a synthesized peptide based on the sequence of the cDNA for GLUT1. A peptide corresponding to the COOH-terminal domain of the GLUT1 glucose transporter (Thr-Pro-Glu-Glu-Leu-Phe-His-Pro-Leu-Gly-Ala-Asp-Ser-Gln-Val) was synthesized and conjugated to keyhole limpet hemocyanin through the NH2-terminal of the peptide. An antibody was raised against this complex and affinity purified with the immobilized peptide. A second peptide, with tyrosine residue added to the NH2-terminal of the above peptide, was synthesized and used as a standard and iodinated for preparation of the radioactive ligand. The assay is highly reproducible, sensitive, and specific for the COOH-terminal domain of the GLUT1 glucose transporter. It has no cross-reactivity with the other glucose-transporter isoforms GLUT2 and GLUT4. Furthermore, the results obtained with this radioimmunoassay on the number of glucose transporters in human erythrocytes were in good agreement with previous studies based on cytochalasin B binding, suggesting that this radioimmunoassay is able to quantify the number of glucose transporters. The assay is completed within 4 h and can be used for simultaneous measurement of GLUT1 in many samples. In addition, it can be applied to the measurement of GLUT1 in several types of tissue.


Asunto(s)
Proteínas de Transporte de Monosacáridos/sangre , Secuencia de Aminoácidos , Eritrocitos/metabolismo , Humanos , Datos de Secuencia Molecular , Proteínas de Transporte de Monosacáridos/genética , Péptidos/síntesis química , Radioinmunoensayo/métodos
5.
Diabetes ; 39(4): 441-6, 1990 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-2180755

RESUMEN

The effect of insulin-deficient diabetic states on the rat liver glucose-transporter (L-transporter isoform) protein and mRNA levels were studied. Rats were injected with 65 mg/kg streptozocin to induce diabetes and were maintained for 10 days and then treated with or without insulin for the next 5 days. The L-transporter isoform with apparent Mr of 55,000 was observed to be increased approximately twofold in the membranes from liver homogenates of diabetic rats compared with control rats when assessed by Western blot analysis with an anti-peptide antibody directed against rat L-transporter isoform. Insulin treatment of diabetic rats decreased the amount of L-transporter isoform protein toward levels observed in nondiabetic rats. Northern blot analysis demonstrated similar alterations in the rat L-transporter isoform mRNA that paralleled the changes observed in the L-transporter isoform protein. The increased levels of the L-transporter isoform protein and mRNA in diabetic rats are in marked contrast to the effects of insulin deficiency in rat adipocytes, which specifically decrease the amount of the adipocyte glucose-transporter isoform protein and mRNA. These results suggest that glucose-transporter isoforms in rat liver and adipocytes are regulated by different mechanisms and that an increased synthesis of the L-transporter isoform may contribute to the increased glucose output that occurs from the liver during insulin deficiency.


Asunto(s)
Diabetes Mellitus Experimental/metabolismo , Hígado/metabolismo , Proteínas de Transporte de Monosacáridos/biosíntesis , ARN Mensajero/genética , Secuencia de Aminoácidos , Animales , Northern Blotting , Western Blotting , Membrana Celular/metabolismo , Diabetes Mellitus Experimental/tratamiento farmacológico , Sueros Inmunes , Insulina/uso terapéutico , Masculino , Datos de Secuencia Molecular , Peso Molecular , Proteínas de Transporte de Monosacáridos/genética , Proteínas de Transporte de Monosacáridos/aislamiento & purificación , Péptidos/síntesis química , ARN Mensajero/metabolismo , Ratas , Ratas Endogámicas , Valores de Referencia
6.
Diabetes ; 41(1): 22-5, 1992 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-1727734

RESUMEN

Previously, demonstrated that GLUT2 mRNA and protein are increased in liver of streptozocin-induced diabetic rats. To examine the mechanisms whereby GLUT2 mRNA is regulated, we cultured isolated hepatocytes in the absence and presence of various concentrations of glucose. Culture of hepatocytes in high glucose concentration (27.8 mM) for 20 h induced a 3.2-fold increase in GLUT2 mRNA levels compared with hepatocytes cultured without D-glucose. Interestingly, D-mannose and D-fructose could substitute for D-glucose to elevate the GLUT2 mRNA level, whereas 3-O-methyl-D-glucose, 2-deoxy-D-glucose, and sucrose, which were not metabolized or taken up by the cells, were without effect. Insulin had no significant effect on GLUT2 mRNA levels in hepatocytes in the presence or absence of D-glucose. Therefore, the regulation of the GLUT2 gene by D-glucose in hepatocytes is contrary to that reported for GLUT1 and GLUT4 genes, which are downregulated by D-glucose. These results also suggest that the elevated GLUT2 mRNA level observed in diabetic rat liver is due to the high blood glucose concentration rather than to insulin deficiency.


Asunto(s)
Fructosa/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Glucosa/farmacología , Hígado/fisiología , Manosa/farmacología , Proteínas de Transporte de Monosacáridos/genética , ARN Mensajero/genética , 3-O-Metilglucosa , Animales , Células Cultivadas , Relación Dosis-Respuesta a Droga , Cinética , Hígado/efectos de los fármacos , Masculino , Metilglucósidos/farmacología , Piruvatos/farmacología , Ácido Pirúvico , ARN Mensajero/metabolismo , Ratas , Ratas Endogámicas
7.
Endocrinology ; 133(5): 2009-14, 1993 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8404647

RESUMEN

We have isolated a clone from the rat jejunum cDNA library using a fragment of human GLUT5 cDNA as a probe. The coding region of this clone shares 80% nucleotide and 81% amino acid identity with human GLUT5 and is thus termed rat GLUT5 cDNA. Rat GLUT5 mRNA exhibited a tissue distribution very similar to that of human GLUT5, with the highest levels in the jejunum, but was not detected in fat, muscle, or testis on Northern blot analysis. The antipeptide antibody raised against the C-terminal domain of rat GLUT5 protein specifically recognized a rat jejunal protein with an apparent mol wt of 60,000 on immunoblots. The amount of GLUT5 mRNA and protein in the jejuni of rats fed a fructose-enriched diet (50%, wt/wt) for 3 days were increased 2.5- and 6-fold, respectively, compared to those of rats fed standard rat chow, whereas those of rats fed a starch-enriched diet (50%, wt/wt) were not altered. Similarly, GLUT5 mRNA and protein in the jejunum were increased 5- and 8-fold, respectively, after 15 days of fructose feeding. Thus, an increase in fructose absorption up-regulates GLUT5 expression in the jejunum. These results are consistent with the notion that GLUT5 plays a major role in fructose absorption in the small intestine.


Asunto(s)
Clonación Molecular , Fructosa/farmacología , Expresión Génica/efectos de los fármacos , Yeyuno/metabolismo , Proteínas de Transporte de Monosacáridos/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , ADN Complementario/química , Fructosa/administración & dosificación , Transportador de Glucosa de Tipo 5 , Humanos , Masculino , Datos de Secuencia Molecular , Proteínas de Transporte de Monosacáridos/química , ARN Mensajero/análisis , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Distribución Tisular
8.
FEBS Lett ; 298(2-3): 129-32, 1992 Feb 24.
Artículo en Inglés | MEDLINE | ID: mdl-1544434

RESUMEN

Digestion of human GLUT1 protein in erythrocytes with 5 micrograms/ml papain for 5 min yielded several fragments. By using several site-specific antibodies, two of these fragments containing the intracellular loop domain between M6 and M7 were demonstrated to be further digested by a prolonged incubation with papain. The addition of 0.2 M D-glucose enhanced this digestion between M6 and M7 by approximately 3.5-fold, while the addition of 0.2 M D-sorbitol exhibited no effects. These results strongly suggest that D-glucose binding induces the conformational change of the intracellular loop domain between M6 and M7 of GLUT1 protein. Since the homology of the amino acid sequence was low in this intracellular domain among the five facilitative glucose transporter isoforms, this intracellular loop might contribute to the difference in their Km and Vmax values for glucose uptake.


Asunto(s)
Membrana Eritrocítica/metabolismo , Glucosa/metabolismo , Proteínas de Transporte de Monosacáridos/metabolismo , Papaína/metabolismo , Humanos , Immunoblotting , Técnicas In Vitro , Proteínas de Transporte de Monosacáridos/química
9.
Neurology ; 52(8): 1705-7, 1999 May 12.
Artículo en Inglés | MEDLINE | ID: mdl-10331707

RESUMEN

Using dot-blot hybridization and Southern blotting, the authors detected a point mutation at nucleotide pair (np) 3243 in mitochondrial DNA from temporal bone sections of a woman with diabetes and deafness. The mutation could not be detected with agarose gel electrophoresis, suggesting that the degree of heteroplasmy is low. Histologically, there was marked degeneration of the stria vascularis and outer hair cells throughout the cochlea, as well as a reduction of spiral ganglion cells in the base. These findings suggest that the mutation affects these inner ear structures preferentially and that deafness can occur even when the proportion of np 3243 mutation is low.


Asunto(s)
ADN Mitocondrial/análisis , Mutación Puntual/genética , ARN de Transferencia de Leucina/genética , Hueso Temporal/patología , Cóclea/patología , Diabetes Mellitus Tipo 1/complicaciones , Femenino , Pérdida Auditiva Sensorineural/complicaciones , Humanos , Persona de Mediana Edad
10.
Immunol Lett ; 9(5): 291-5, 1985.
Artículo en Inglés | MEDLINE | ID: mdl-3158601

RESUMEN

Human large granular lymphocytes (LGL) were cultured with autologous dense T lymphocytes for 0-8 days. The mixed LGL dense T cell cultures had enhanced lytic activity against K562 on day 4, as compared to LGL cultured alone. Dense T cells cultured alone had no K562 lytic activity. The mixed LGL dense T cell cultures were reseparated on day 4 into low dense SRBC- and SRBC+ and into high dense subsets. Both low dense subsets did lyse K562 whereas the high dense subset did not lyse K562. Since the LGL population was the low dense SRBC- cells, the results suggested that the day 4 low dense SRBC+ cytotoxic population in the mixed LGL dense T cell culture originated from noncytotoxic dense T cells. Dense T cells were also separated into OKT8- and OKT8+ subsets and cultured together with LGL for 0-8 days. The LGL dense OKT8- T cell coculture had enhanced K562 lytic activity while the LGL dense OKT8+ T cell coculture had no enhanced lytic activity, as compared to LGL cultured alone. These results indicated that LGL interacted with the dense OKT8- T cells to produce the enhanced K562 lysis.


Asunto(s)
Células Asesinas Naturales/inmunología , Linfocitos T/inmunología , Anticuerpos Monoclonales , Recuento de Células , Citotoxicidad Inmunológica , Humanos , Técnicas In Vitro , Prueba de Cultivo Mixto de Linfocitos
11.
Metabolism ; 46(2): 199-202, 1997 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9030829

RESUMEN

Prompted by the recent findings that a tryptophan to arginine (Trp64Arg) mutation in the beta3-adrenergic receptor gene was associated with an earlier onset of non-insulin-dependent diabetes mellitus (NIDDM) in Pima Indians, with abdominal obesity and insulin resistance in Finns, and with an increased capacity to gain weight in French whites, we studied the prevalence of this mutation in 231 diabetic and 95 nondiabetic Japanese subjects and assessed its contribution to the development of obesity and NIDDM. The allelic frequencies of the mutation were 0.18 in diabetic and 0.23 in nondiabetic subjects, showing no significant difference between the two groups (P = .067). In nondiabetic subjects, body mass index (BMI) did not differ between those with and without the mutation (22.2 +/- 3.5 v 21.4 +/- 3.2 kg/m2, P = .252). In NIDDM subjects, BMI at the time of study and maximal BMI before the start of treatment did not differ between those with and without the mutation (22.8 +/- 2.6 v 23.2 +/- 3.7 kg/m2, P = .678, and 24.7 +/- 2.6 v 24.9 +/- 3.1 kg/m2, P = .277). Homozygotes for the mutation did not have trends to have increased BMI in either diabetic or nondiabetic subjects. The age at diagnosis of NIDDM also did not differ between the two groups (48.8 +/- 9.9 v 47.8 +/- 12.5 years, P = .796). Fasting serum cholesterol and triglyceride levels and systolic and diastolic blood pressure before the start of treatment did not differ between NIDDM subjects with and without the mutation. In conclusion, although the Trp64Arg mutation is not uncommon in Japanese, it does not appear to be associated with obesity, NIDDM, age at diagnosis of NIDDM, or dyslipidemia. Our results suggest that the mutation has minor effects, if any, on the development of obesity and NIDDM in Japanese.


Asunto(s)
Receptores Adrenérgicos beta/genética , Adulto , Anciano , Alelos , Arginina , Diabetes Mellitus/epidemiología , Diabetes Mellitus/genética , Diabetes Mellitus Tipo 2/epidemiología , Diabetes Mellitus Tipo 2/genética , Femenino , Humanos , Japón/epidemiología , Masculino , Persona de Mediana Edad , Obesidad/epidemiología , Obesidad/genética , Mutación Puntual , Receptores Adrenérgicos beta 3 , Triptófano
12.
Int J Hematol ; 67(3): 319-29, 1998 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9650454

RESUMEN

Evolution of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) into aggressive B cell lymphoma is thought to be a rare event and the cause of this transformation has not been fully elucidated. We describe two patients with AILD that progressed to aggressive large-cell lymphoma with a B cell phenotype. At presentation, the lymph nodes of both patients showed the typical features of AILD by hematoxylin-eosin staining. Immunohistochemical staining with monoclonal antibodies revealed positive staining of atypical cells with UCHL-1 and negative staining with L-26. In situ hybridization of EBV RNA showed rare positive cells in one patient and was negative in the other patient. At relapse, both patients showed systemic lymph nodes swelling, which is characteristic of diffuse large immunoblastic lymphoma. Single-cell analysis with monoclonal antibodies and immunohistochemical staining showed the monoclonal proliferation of B cells. Southern blot analysis of the lymph nodes showed a rearrangement in both patients of the Ig heavy chain gene and germ line configuration of the T cell receptor beta chain gene. Southern blot analysis using the EBV terminal repeat region probe detected clonal proliferation of EBV in the lymph nodes of both patients. In situ hybridization studies identified considerable EBV mRNA in both patients. These observations suggest that EBV proliferation plays an important role in the development of B cell lymphoma that arises from AILD. We suggest that infection or reactivation of EBV may occur in some patients with AILD, probably due to their immunodeficient state, and that this infection or reactivation is directly involved in the development of B cell lymphoma.


Asunto(s)
Herpesvirus Humano 4/aislamiento & purificación , Linfadenopatía Inmunoblástica/complicaciones , Linfadenopatía Inmunoblástica/tratamiento farmacológico , Linfoma de Células B/etiología , Linfoma de Células B Grandes Difuso/etiología , Proteínas/metabolismo , Infecciones por Herpesviridae/etiología , Infecciones por Herpesviridae/patología , Humanos , Linfadenopatía Inmunoblástica/metabolismo , Linfoma de Células B/virología , Linfoma de Células B Grandes Difuso/virología , Masculino , Persona de Mediana Edad , Infecciones Tumorales por Virus/etiología , Infecciones Tumorales por Virus/patología
13.
Int J Hematol ; 72(2): 200-5, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11039669

RESUMEN

Forty-nine adult patients with high-risk myelodysplastic syndrome (MDS) or acute myeloid leukemia that progressed from MDS were registered for the multicenter study of the Japan Adult Leukemia Study Group. Forty-three patients were evaluable for the analysis. Idarubicin 12 mg/m2 per day for 3 days and continuous cytosine arabinoside 100 mg/m2 per day for 7 days were given as induction therapy, followed by postremission chemotherapy after complete remission (CR). Because elderly patients and those with hypoplastic marrow usually have complications after intensive chemotherapy, often causing early death, the treatment dose was reduced to 60% or 80% according to the presence of 3 risk factors: age 60 years or older, performance status 2 or more, or presence of hypoplastic bone marrow. Of the 43 evaluable patients (median age, 58 years), 26 (60%) achieved CR. Two patients (5%) died within 2 months of completion of induction therapy. The CR rates for patients treated with 100%, 80%, and 60% of the chemotherapy dose were 55% (12 of 22), 63% (10 of 16), and 80% (4 of 5), respectively, indicating that the risk factor-adjusted dose attenuation was appropriately applied to those who might have had problems with the original dose, thus reducing regimen-related mortality rate. The median overall survival of the 43 patients was 8 months.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Leucemia Mieloide/tratamiento farmacológico , Síndromes Mielodisplásicos/tratamiento farmacológico , Enfermedad Aguda , Adulto , Factores de Edad , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/toxicidad , Médula Ósea/patología , Citarabina/administración & dosificación , Citarabina/toxicidad , Femenino , Humanos , Idarrubicina/administración & dosificación , Idarrubicina/toxicidad , Japón/epidemiología , Cariotipificación , Leucemia Mieloide/mortalidad , Masculino , Persona de Mediana Edad , Síndromes Mielodisplásicos/mortalidad , Inducción de Remisión/métodos , Factores de Riesgo , Tasa de Supervivencia
14.
Brain Res ; 213(1): 201-4, 1981 May 25.
Artículo en Inglés | MEDLINE | ID: mdl-7237144

RESUMEN

Thirty units were found in the midbrain of the anesthetized cat which discharged in correlation with spontaneously occurring lens accommodation. The frequency of spike potentials increased before the onset of the accommodation response. Increased discharges were followed by a silent period. These units were driven orthodromically by stimulating the interpositus nucleus of the cerebellum and the posterior commissure. Eleven of these units were identified antidromically as parasympathetic oculomotor neurons.


Asunto(s)
Cristalino/inervación , Mesencéfalo/fisiología , Neuronas/fisiología , Nervio Oculomotor/fisiología , Animales , Axones/fisiología , Gatos , Conductividad Eléctrica , Potenciales Evocados , Cristalino/fisiología
15.
Brain Res ; 225(1): 195-9, 1981 Nov 23.
Artículo en Inglés | MEDLINE | ID: mdl-7296275

RESUMEN

Single-unit discharges in the cat Clare-Bishop area were correlated with spontaneous accommodation responses. No appreciable change was found in accommodation responses evoked by stimulating the Clare-Bishop area, when cerebellar outflow was blocked reversibly by cooling the superior cerebellar peduncle. It is suggested, therefore, that the Clare-Bishop area plays an important role in the lens accommodation system through a pathway independent from that of the cerebellum.


Asunto(s)
Acomodación Ocular , Corteza Cerebral/fisiología , Cristalino/inervación , Animales , Gatos , Potenciales Evocados Visuales , Neuronas/fisiología , Corteza Visual/fisiología
16.
Urol Oncol ; 21(1): 27-32, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12684124

RESUMEN

The presence of tumor infiltrating lymphocytes (TIL) has been attributed to the host cell mediated immune response against the evolving malignancy. However, due to specific evasive and escape mechanisms, the immune competent cells are rendered ineffective. One such mechanism may be the production of immune suppressor substance(s), inhibiting lymphocyte proliferation, and subsequently, their transformation into effector cells. To evaluate a possible impact of RCC extract on lectin and alloantigen-induced proliferation of TIL and peripheral blood lymphocytes (PBL) from renal cell carcinoma (RCC) patients and from healthy control human subjects. Tumor extract and TIL were derived from 13 patients with RCC undergoing radical nephrectomy. Tumor infiltrating lymphocytes and PBL from these patients were activated with Concanavalin A (Con-A), Phytohemoglutinine (PHA) or Pokeweed (PW) and the rate of blastogenesis was measured by (3)H Thymidine incorporation. The same procedure was used in assay with PBL from control healthy blood donors. There was a significant reduction (88.6%) in the proliferative response to ConA of TIL compared to PBL from the same patients (P = 0.007). A similar decrease was seen following stimulation by PHA (85.8%, P = 0.01) and PW mitogen (78.5%, P = 0.001). A 79.5% decrease in response level of TIL to alloantigens compared to PBL from RCC patients (P = 0.021), was observed. Lectin induced proliferative response of RCC patients was significantly lower in the presence of RCC extract (82.9%) compared to normal kidney extract (P = 0.008). Alloantigenic stimulation of healthy individual PBL was also decreased significantly in the presence of RCC extract (92.9%, P = 0.0001) compared to normal kidney extract. Similarly, lectin induced stimulation of healthy control PBL in the presence of RCC extract was significantly lower (83.2%, P = 0.003). Our data suggest that RCC extract contains an immune suppressive substance(s), capable of inhibiting lymphocyte proliferative response of tumor infiltrating lymphocytes as well as of PBL from patients and healthy individuals alike. This may be one of the mechanisms by which the tumor evades the transformation of lymphocytes into effector killer cells, and thus affects the biological inter-relationship between tumor and host. Identification of this substance and its gene may provide an effective anti-tumoral treatment modality.


Asunto(s)
Adenocarcinoma de Células Claras/química , Carcinoma de Células Renales/química , Concanavalina A/farmacología , Isoantígenos/inmunología , Neoplasias Renales/química , Activación de Linfocitos/efectos de los fármacos , Linfocitos Infiltrantes de Tumor/efectos de los fármacos , Fitohemaglutininas/farmacología , Mitógenos de Phytolacca americana/farmacología , Extractos de Tejidos/farmacología , Adenocarcinoma de Células Claras/inmunología , Anciano , Factores Biológicos/aislamiento & purificación , Factores Biológicos/farmacología , Células Sanguíneas/efectos de los fármacos , Carcinoma de Células Renales/inmunología , Carcinoma de Células Transicionales/química , Carcinoma de Células Transicionales/inmunología , Células Cultivadas/efectos de los fármacos , Femenino , Humanos , Tolerancia Inmunológica , Riñón/química , Neoplasias Renales/inmunología , Linfocitos Infiltrantes de Tumor/inmunología , Masculino , Persona de Mediana Edad , Especificidad de Órganos , Extractos de Tejidos/aislamiento & purificación
17.
Laryngoscope ; 106(1 Pt 1): 49-53, 1996 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-8544627

RESUMEN

Five patients with sensorineural hearing loss, who harbored a point mutation in the mitochondrial transfer RNA (tRNA) gene tRNA(Leu) (UUR), from five unrelated family pedigrees were examined. In these families diabetes and deafness were maternally inherited. Bilateral hearing was more severely impaired at higher frequencies. Audiometric test results revealed that hearing loss involved the cochlea. Hearing gradually deteriorated; the progression rate ranged from 1.5 to 7.9 dB per year. Proportion of mutant mitochondrial DNAs (mtDNAs) in the leukocytes was not related to the rate or degree of hearing loss, although hearing loss appeared at a younger age in patients with higher heteroplasmy. We speculate that after the proportion of damaged mtDNAs, mostly as a result of mutation, exceeds the expression threshold for deficiencies in mitochondrial protein synthesis and oxygen consumption, a drop in adenosine triphosphate level could lead to an imbalance of ion concentration, resulting in cell death in the cochlea.


Asunto(s)
Cóclea/fisiopatología , ADN Mitocondrial/genética , Diabetes Mellitus/genética , Pérdida Auditiva Sensorineural/genética , Pérdida Auditiva Sensorineural/fisiopatología , Mutación Puntual , ARN de Transferencia/genética , Adulto , Secuencia de Aminoácidos , Audiometría de Tonos Puros , Femenino , Humanos , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular
18.
Am J Clin Oncol ; 17(6): 470-4, 1994 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7977162

RESUMEN

A 27-year-old woman developed generalized subcutaneous painful nodules, fever, abnormal liver function, a bleeding tendency, and pancytopenia. Skin biopsies revealed the lobular panniculitis with a morphologically benign histiocytic infiltration with prominent phagocytosis. Leukophagocytosis and erythrophagocytosis were also present in the bone marrow. The diagnosis of cytophagic histiocytic panniculitis was made. The patient received polychemotherapy with cyclophosphamide, Adriamycin, and vincristine on day 1, prednisone on day 1-5 (modified CHOP), with the addition of etoposide (E). This regimen was repeated 8 times every 3 weeks. The patient obtained a complete clinical remission that has lasted almost 2 years after the completion of chemotherapy. Thus we suggest modified CHOP-E chemotherapy for an effective treatment for the aggressive form of cytophagic histiocytic panniculitis.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Paniculitis/tratamiento farmacológico , Adulto , Ciclofosfamida/administración & dosificación , Doxorrubicina/administración & dosificación , Etopósido/administración & dosificación , Femenino , Humanos , Paniculitis/diagnóstico , Prednisona/administración & dosificación , Inducción de Remisión , Vincristina/administración & dosificación
19.
Ann Thorac Cardiovasc Surg ; 7(2): 122-4, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11371286

RESUMEN

In an operation involving coronary bypass grafting, anastomoses to the ascending aorta with saphenous vein or radial artery grafts may increase the possibility of post-operative strokes by the dislodgement of embolic particles into the arterial vasculature. We report a bi-directional single anastomotic technique to decrease the possibility of intra and postoperative strokes and to allow earlier cardiac perfusion by the graft anastomosed to the ascending aorta, in case of CABG with 2 free grafts from there.


Asunto(s)
Aorta/cirugía , Puente de Arteria Coronaria/efectos adversos , Puente de Arteria Coronaria/métodos , Arteria Radial/trasplante , Vena Safena/trasplante , Accidente Cerebrovascular/etiología , Accidente Cerebrovascular/prevención & control , Anastomosis Quirúrgica/métodos , Angiografía Coronaria , Enfermedad Coronaria/diagnóstico por imagen , Enfermedad Coronaria/cirugía , Estudios de Seguimiento , Humanos , Técnicas de Sutura , Resultado del Tratamiento
20.
Jpn J Thorac Cardiovasc Surg ; 48(12): 795-801, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11197824

RESUMEN

OBJECTIVE: A single surgeon conducted One hundred and twelve patients underwent minimally invasive direct coronary artery bypass grafting for the left anterior descending coronary artery 112 patients at Yamato Seiwa Hospital from September 1996 until August 1999. METHODS: All procedures were performed via left anterior short thoracotomy using a stabilizer during graft anastomosis. RESULTS: No operative deaths occurred but 3 patients died while hospitalized due to noncardiac events. Graft occlusion was seen in 3 patients early postoperatively. Other angiography graft failure such as stenosis was seen in 11 patients. Occlusive lesions of other coronary arteries occurred in 77 patients (69%) and 53 patients underwent percutaneous transluminal coronary angioplasty the pre/postoperatively for those lesions. CONCLUSIONS: These results suggest that minimally invasive direct coronary artery bypass grafting is seen by cardiologists as a reasonable form of revascularization in conditioned patients having left anterior descending artery lesion, and that minimally invasive direct coronary artery bypass grafting has a spectrum of candidates different from that of conventional surgical revascularization for the coronary artery.


Asunto(s)
Puente de Arteria Coronaria , Vasos Coronarios/cirugía , Procedimientos Quirúrgicos Mínimamente Invasivos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Angioplastia Coronaria con Balón , Niño , Enfermedad Coronaria/cirugía , Enfermedad Coronaria/terapia , Femenino , Humanos , Masculino , Persona de Mediana Edad , Grado de Desobstrucción Vascular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA